Filing Details
- Accession Number:
- 0001615774-17-006777
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-16 06:03:54
- Reporting Period:
- 2017-11-15
- Accepted Time:
- 2017-11-16 06:03:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1488039 | Atossa Genetics Inc | ATOS | Pharmaceutical Preparations (2834) | 264753208 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1566618 | Kyle Guse | C/O Atossa Genetics Inc. 107 Spring Street Seattle WA 98104 | Cfo, Gen Counsel And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-15 | 8,600 | $0.34 | 8,600 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-11-15 | 1,400 | $0.34 | 10,000 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Billionaire Hedge Funds
